Surgical Treatments — Lymphedema and Lipedema (Medical Coverage Policy)
Customize your policy alerts
Sign up for all Blue Cross Blue Shield - Rhode Island policy alerts
Know when Blue Cross Blue Shield - Rhode Island releases new policies or updates existing guidance.
Monitor payer policy activity
Covers medical necessity criteria, required documentation, and prior authorization for surgical procedures to treat lymphedema and lipedema for Medicare Advantage and commercial products.
No material clinical or coverage changes in this revision.
Coverage Criteria — Lymphedema & Lipedema Surgical Treatments
Lymph Node Transplant — Medical Necessity
Lymph node transplant may be considered medically necessary when ALL of the following are met:
Lymphovenous Bypass — Medical Necessity
Lymphovenous bypass may be considered medically necessary when ALL of the following are met:
Debulking of a Limb — Medical Necessity
Debulking may be considered medically necessary when ALL of the following are met:
Lipedema Surgical Treatment — Medical Necessity
Liposuction/excision/debulking for lipedema may be considered medically necessary when ALL of the following are met:
Medically necessary surgical interventions
Covered when ALL of the following are met:
Claims must include correct diagnosis codes
Includes failed conservative therapy prerequisites
Only when the above criteria are satisfied
May be staged if aspirate exceeds clinical standards (>5000 cc)
Not covered / insufficient evidence
Procedures considered not covered / insufficient evidence when:
Policy lists specific procedures with insufficient evidence
Liposuction for treatment of lipedema — general coverage stance
Covered when ALL of the following are met
general
- staging: If total aspirate volume would exceed 5,000 cc, procedures should be staged in accordance with facility guidance.>5000 cc
ASPS practice advisory and policy text
The policy excludes individuals with transient lymphedema (defined as swelling that meets lymphedema thresholds occurring within 6 months of the last oncologic treatment), and excludes patients with lipedema without lymphatic dysfunction from lymphedema-specific surgical interventions. Other clinical exclusions that may preclude surgical eligibility include uncontrolled comorbidities such as venous disease (e.g., DVT), congestive heart failure (CHF), medication-induced swelling, liver disease (including cirrhosis or hypoproteinemia), and nephropathy/end-stage renal disease. Pregnancy, documented dye anaphylaxis, and active infection of the affected extremity (e.g., cellulitis/erysipelas) are also listed exclusions.
The policy requires that surgical treatment be performed by a hospital-credentialed, board-certified plastic surgeon, and indicates these exclusions apply across the lymphedema procedures described (lymph node transplant, lymphovenous bypass, and debulking).
Repeat liposuction in areas that have been fully treated is explicitly considered not covered for Medicare Advantage Plans and not medically necessary for Commercial products. The policy also states that procedures are only considered medically necessary when filed with the appropriate ICD-10 diagnosis codes and when the policy medical criteria are met; failure to meet those criteria or to file with the specified diagnoses may render the procedure not covered.
Large-volume liposuction that exceeds clinical standards for a single surgery (see staging thresholds) should be completed in stages as clinically appropriate; staged liposuction is described as medically necessary when the medical criteria are met and staging is used to limit per-procedure aspirate volumes.
Claims for lipectomy or suction-assisted lipectomy must be filed with one of the listed primary ICD-10-CM diagnosis codes (for example, E65 or E88.2 for lipectomy/liposuction related to adiposity/lipomatosis), and claims filed with other diagnosis codes may deny as not covered. The policy reiterates that the CPT codes identified for debulking and lipectomy are medically necessary only when the listed ICD-10-CM diagnosis codes appear in the primary position.
More broadly, surgical procedures for lymphedema or lipedema are considered medically necessary only when filed with the appropriate ICD-10 diagnosis code for lymphedema, postmastectomy lymphedema syndrome, adiposity, or lipomatosis as applicable; incorrect diagnostic filing increases the risk of denial.
The policy reminds providers that services determined to be not medically necessary or otherwise non-covered benefits are excluded from payment. Providers may not charge the member for such services unless the member has been informed in advance and has agreed in writing to accept financial responsibility. For member-specific benefit or eligibility questions, providers are directed to the provider call center and the member's subscriber agreement or certificate.
The policy lists several surgical procedures as having insufficient evidence and therefore not covered for Medicare Advantage Plans and not medically necessary for Commercial products. These include lymphatico-lymphatic bypass, lymphaticovenous anastomosis, vascularized lymph node transfer (VLNT), and lymphatic physiologic microsurgery performed during nodal dissection or breast reconstruction (including LYMPHA) when used to prevent lymphedema.
When evidence is insufficient to determine health outcome effects for these procedures, the policy treats them as not covered / not medically necessary under the stated product types.
The policy notes that much of the literature for surgical treatments—particularly for liposuction in lipedema and many microsurgical procedures for lymphedema—consists of single-arm studies, case series, consensus articles, and reviews. Many studies used patients as their own controls and did not compare outcomes to decongestive therapy alone, limiting the ability to attribute benefit solely to the procedure.
These methodological limitations—single-arm designs and lack of contemporaneous comparators—contribute to the policy's assessment of insufficient evidence for several procedures and are reflected in the not-covered determinations.
The document does not provide a separate set of explicit clinical criteria that would categorically define a service as not medically necessary; rather, it states that certain procedures may be determined not medically necessary for Commercial products and not covered for Medicare Advantage Plans when the evidence is insufficient or when the policy's medical and diagnostic criteria are not met.
In practice, this means services that lack supporting evidence or that are performed without meeting the specified diagnostic, conservative-therapy, or documentation requirements may be denied as not medically necessary and therefore non-covered.
Coding — CPT/ICD-10 and Coding Rules
| No codes listed |
| No codes listed |
| 15832 | Excision, excessive skin and subcutaneous tissue (includes lipectomy); thigh |
| 15833 | Excision, excessive skin and subcutaneous tissue (includes lipectomy); leg |
| 15834 | Excision, excessive skin and subcutaneous tissue (includes lipectomy); hip |
| 15835 | Excision, excessive skin and subcutaneous tissue (includes lipectomy); buttock |
| 15836 | Excision, excessive skin and subcutaneous tissue (includes lipectomy); arm |
| 15878 | Suction assisted lipectomy; upper extremity |
| 15879 | Suction assisted lipectomy; lower extremity |
| 1019T | Lymphovenous bypass, including robotic assistance, when performed, per extremity (new Code Effective 1/1/2026) |
| 38999 | Unlisted procedure, hemic or lymphatic system (used for lymph node transplant and other unlisted lymphatic procedures) |
| I89.0 | Lymphedema, not elsewhere classified |
| I97.2 | Postmastectomy lymphedema syndrome |
| E65 | Localized adiposity |
| E88.2 | Lipomatosis, not elsewhere classified |
Provider Actions — Authorization, Documentation & Billing Requirements
Prior authorization requirement
Prior authorization must be obtained for Medicare Advantage members and is recommended for Commercial products; verify requirements for the specific member prior to scheduling.
File procedures with the correct ICD-10 diagnosis
Surgical procedures for lymphedema or lipedema are considered medically necessary only when filed with the appropriate ICD-10 diagnosis codes and when the medical criteria in the policy are met; claims filed without the specified diagnosis codes may be denied.
CPT/diagnosis pairing required on claims
The CPT codes listed for lipectomy and suction-assisted lipectomy are medically necessary only when the policy’s medical criteria are met and must be filed with the specified primary ICD-10-CM diagnosis codes; claims with other diagnosis codes may deny as not covered.
Confirm member-specific authorization details
Refer to member-specific benefit documents and contact the provider call center for details on prior authorization, eligibility, and benefit limitations for the individual member.
Conservative therapy prerequisite before surgery
Completion of a conservative therapy regimen is required before surgical procedures will be considered; the policy defines this as lymphedema therapy at a minimum intensity and duration.
- Minimum requirement: lymphedema therapy for at least 20 hours per week for 6 months.
Document conservative therapy modalities attempted
Ensure the medical record documents attempted conservative modalities prior to surgery; conservative care includes education, skin care, weight management, limb elevation, manual lymphatic drainage, compression garments, decongestive therapy, and pneumatic pumps.
- Education and skin care
- Weight management and supervised weight-loss interventions (when applicable)
- Limb elevation
- Manual lymphatic drainage / complete decongestive therapy
- Compression garments or bandaging
- Intermittent sequential pneumatic compression / pneumatic pumps
- Targeted exercises for lymphedema
Decongestive lymphatic therapy required prior to considering surgery
Decongestive lymphatic therapy (complete decongestive therapy/manual lymphatic drainage) is the initial treatment approach; many surgical series describe patients who failed at least 6 months of conservative therapy before surgery is considered.
- Document failure of conservative care (e.g., persistent symptoms after ≥6 months) before considering surgical options.
Required clinical documentation to support medical necessity
Include clinical documentation in the medical record that supports surgical necessity: diagnosis, photographs for lipedema, quantitative measurements (volumetry/perometry, bioimpedance/L‑Dex, lymphoscintigraphy or ICG findings), evidence of completed conservative therapy, BMI, and notes on functional impairment and tolerance of compression/therapy.
- Photographs documenting lipedema and cuff phenomenon (when applicable)
- Volumetry/perometry differentials or bioimpedance (L‑Dex) measurements
- Lymphoscintigraphy or ICG lymphangiography results as required by procedure
- Documentation of ≥20 hrs/week × 6 months conservative therapy
- BMI documented (policy threshold ≤ 35 kg/m2)
- Clinical notes describing functional impairment and postoperative compression tolerance
Use required primary ICD-10-CM diagnosis codes on claims
File procedures with the appropriate primary ICD-10-CM diagnosis codes listed in the policy (e.g., I89.0, I97.2 for debulking; E65, E88.2 for lipectomy/liposuction) — claims with other primary diagnoses may deny as not covered.
- Debulking primary diagnoses examples: I89.0, I97.2
- Lipectomy/liposuction primary diagnoses examples: E65, E88.2
Facility and staging requirements for large-volume liposuction
Large-volume liposuction (total aspirate >5,000 cc) should be performed in an acute-care hospital or an accredited/licensed facility, and large-volume procedures should be staged when total aspirate would exceed 5,000 cc per procedure.
- Plan staging if expected total aspirate > 5,000 cc; consider completion within a 12-month period when staged.
Benefit verification before scheduled services
Verify member benefits and eligibility with the provider call center before scheduling; member-specific subscriber agreements or employer contracts determine coverage and supersede policy language.
Clinical exclusion risks that may cause denial
Do not proceed with surgery for members who have uncontrolled comorbidities (active infection, venous disease, CHF, liver disease, nephropathy), are pregnant, have dye anaphylaxis, or have transient lymphedema within 6 months post-oncologic treatment; these conditions may preclude eligibility and trigger denial.
- Screen for active infection of the affected extremity (cellulitis/erysipelas)
- Confirm no recent oncologic treatment within 6 months for transient lymphedema
Coverage contingent on meeting criteria and correct diagnosis
Coverage is contingent on meeting the policy’s medical criteria and using the specified diagnosis codes; procedures may be considered not covered for Medicare Advantage and not medically necessary for Commercial products when criteria or diagnoses are not met.
Repeat liposuction in fully treated areas is excluded
Repeat liposuction in areas that have been fully treated is considered not covered for Medicare Advantage and not medically necessary for Commercial products; do not bill for repeat procedures in fully treated areas as medically necessary.
Primary diagnosis must match policy-listed ICD-10-CM codes
Claims filed with diagnosis codes other than the listed primary ICD-10-CM codes for the procedure may be denied as not covered; ensure the primary diagnosis on the claim matches the policy-specified codes.
Member financial consent required for non-covered services
If services are determined to be not medically necessary or are non-covered benefits, the provider may not charge the member unless the member was informed and provided written agreement in advance to pay for the non-covered services.
- Obtain written informed financial consent from the member before providing non-covered services.
Ensure correct primary ICD-10-CM is billed
Ensure the primary ICD-10-CM diagnosis on claims is one of the policy-listed codes (e.g., I89.0, I97.2, E65, E88.2); claims with other primary diagnoses may deny as not covered.
Definitions & Terms
Background — Clinical Context
Lymphedema is an accumulation of interstitial fluid due to disrupted lymphatic drainage and may be primary or secondary. The policy references the International Society of Lymphology staging where Stage I is reversible with limb elevation, Stage II does not resolve with elevation and may show fibrosis, and Stage III corresponds to lymphostatic elephantiasis with trophic skin changes.
Lipedema is described as a progressive disorder of subcutaneous adipose overgrowth—typically bilateral and symmetric in the hips, buttocks, and extremities—that does not respond to standard weight-loss interventions and is diagnosed by clinical and physical findings because no diagnostic test exists. Lipedema can coexist with lymphedema (lipolymphedema) when lymphatic compromise is present.
The policy frames surgical options (lymph node transplant, lymphovenous bypass, and debulking/liposuction for lipedema) as potential treatments for refractory cases when objective measures (e.g., volumetry differentials, bioimpedance, lymphoscintigraphy/ICG) and conservative therapy prerequisites have been met, and emphasizes required documentation and credentialing for surgical providers.
Revision History
Policy effective date established.
For member-specific benefits and prior authorization details, providers must refer to the member subscriber agreement or call the provider call center; services determined not medically necessary may not be charged to members without prior written consent.
Prior authorization is required for Medicare Advantage Plans and recommended for Commercial Products.
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.